NDRA - エンドラ・ライフ・サイエンシズ (ENDRA Life Sciences Inc.)

NDRAのニュース

   ENDRA Life Sciences Granted 13th U.S. Patent for its TAEUS(R) Platform Technology  2021/01/13 14:00:00 Yahoo Finance
Now Has 78 Patents Issued, Filed, Licensed or in Preparation As Taeus® Commercial Launch Plans AdvanceANN ARBOR, MI / ACCESSWIRE / January 13, 2021 /ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued United States Patent 10888898 (the '898 patent) entitled "Shielded Ultrasound Transducer and Imaging System Employing the Same" from the United States Patent and Trademark Office.
   ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option - Stocks News Feed  2020/12/18 17:39:27 Stocks News Feed
ANN ARBOR, MI / ACCESSWIRE / December 18, 2020 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today reported the closing of its previously announced underwritten public offering of 7,143,000 shares of common stock at an offering price of $0.70 per share. In connection with the offering, the underwriter exercised… Read More »ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option
   ENDRA Life Sciences Announces Pricing of Public Offering of Common Stock - Stocks News Feed  2020/12/16 05:39:01 Stocks News Feed
ANN ARBOR, MI / ACCESSWIRE / December 15, 2020 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today announced the pricing of an underwritten public offering of 7,143,000 shares of common stock at an offering price of $0.70 per Common Share. In addition, ENDRA has granted the underwriter a 45-day… Read More »ENDRA Life Sciences Announces Pricing of Public Offering of Common Stock
   ENDRA Life Sciences Announces New Clinical Study Partnership with the Centre Hospitalier Universitaire d'Angers, France - Stocks News Feed  2020/12/03 14:38:55 Stocks News Feed
Study to Bolster Clinical Evidence of Performance of Patented TAEUS Ultrasound Device in NAFLD Patients as Commercialization Begins ANN ARBOR, MI / ACCESSWIRE / December 3, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that Centre Hospitalier Universitaire d’Angers, France (CHU Angers), a world-renowned healthcare institution, is… Read More »ENDRA Life Sciences Announces New Clinical Study Partnership with the Centre Hospitalier Universitaire d’Angers, France
   ENDRA Life Sciences (NASDAQ:NDRA) versus IMRIS (NASDAQ:IMRSQ) Head to Head Comparison  2020/10/25 09:08:51 Dakota Financial News
ENDRA Life Sciences (NASDAQ:NDRA) and IMRIS (OTCMKTS:IMRSQ) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Institutional and Insider Ownership 3.5% of ENDRA Life Sciences shares are owned by institutional investors. 9.6% […]
   ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option - Stocks News Feed  2020/12/18 17:39:27 Stocks News Feed
ANN ARBOR, MI / ACCESSWIRE / December 18, 2020 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today reported the closing of its previously announced underwritten public offering of 7,143,000 shares of common stock at an offering price of $0.70 per share. In connection with the offering, the underwriter exercised… Read More »ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option
   ENDRA Life Sciences Announces Pricing of Public Offering of Common Stock - Stocks News Feed  2020/12/16 05:39:01 Stocks News Feed
ANN ARBOR, MI / ACCESSWIRE / December 15, 2020 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today announced the pricing of an underwritten public offering of 7,143,000 shares of common stock at an offering price of $0.70 per Common Share. In addition, ENDRA has granted the underwriter a 45-day… Read More »ENDRA Life Sciences Announces Pricing of Public Offering of Common Stock
   ENDRA Life Sciences Announces New Clinical Study Partnership with the Centre Hospitalier Universitaire d'Angers, France - Stocks News Feed  2020/12/03 14:38:55 Stocks News Feed
Study to Bolster Clinical Evidence of Performance of Patented TAEUS Ultrasound Device in NAFLD Patients as Commercialization Begins ANN ARBOR, MI / ACCESSWIRE / December 3, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that Centre Hospitalier Universitaire d’Angers, France (CHU Angers), a world-renowned healthcare institution, is… Read More »ENDRA Life Sciences Announces New Clinical Study Partnership with the Centre Hospitalier Universitaire d’Angers, France
   ENDRA Life Sciences (NASDAQ:NDRA) versus IMRIS (NASDAQ:IMRSQ) Head to Head Comparison  2020/10/25 09:08:51 Dakota Financial News
ENDRA Life Sciences (NASDAQ:NDRA) and IMRIS (OTCMKTS:IMRSQ) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Institutional and Insider Ownership 3.5% of ENDRA Life Sciences shares are owned by institutional investors. 9.6% […]
   ENDRA Life Sciences (NASDAQ:NDRA) and IMRIS (NASDAQ:IMRSQ) Critical Analysis  2020/10/23 01:42:49 The Lincolnian
ENDRA Life Sciences (NASDAQ:NDRA) and IMRIS (OTCMKTS:IMRSQ) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Analyst Ratings This is a breakdown of recent ratings and price targets for ENDRA Life Sciences […]
   ENDRA Life Sciences Announces New Clinical Study Partnership with the Centre Hospitalier Universitaire d'Angers, France - Stocks News Feed  2020/12/03 14:38:55 Stocks News Feed
Study to Bolster Clinical Evidence of Performance of Patented TAEUS Ultrasound Device in NAFLD Patients as Commercialization Begins ANN ARBOR, MI / ACCESSWIRE / December 3, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that Centre Hospitalier Universitaire d’Angers, France (CHU Angers), a world-renowned healthcare institution, is… Read More »ENDRA Life Sciences Announces New Clinical Study Partnership with the Centre Hospitalier Universitaire d’Angers, France
   ENDRA Life Sciences (NASDAQ:NDRA) versus IMRIS (NASDAQ:IMRSQ) Head to Head Comparison  2020/10/25 09:08:51 Dakota Financial News
ENDRA Life Sciences (NASDAQ:NDRA) and IMRIS (OTCMKTS:IMRSQ) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Institutional and Insider Ownership 3.5% of ENDRA Life Sciences shares are owned by institutional investors. 9.6% […]
   ENDRA Life Sciences (NASDAQ:NDRA) and IMRIS (NASDAQ:IMRSQ) Critical Analysis  2020/10/23 01:42:49 The Lincolnian
ENDRA Life Sciences (NASDAQ:NDRA) and IMRIS (OTCMKTS:IMRSQ) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Analyst Ratings This is a breakdown of recent ratings and price targets for ENDRA Life Sciences […]
   Reviewing IMRIS (OTCMKTS:IMRSQ) and ENDRA Life Sciences (OTCMKTS:NDRA)  2020/10/22 22:42:48 Daily Political
IMRIS (OTCMKTS:IMRSQ) and ENDRA Life Sciences (NASDAQ:NDRA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. Analyst Recommendations This is a summary of current recommendations and price targets for IMRIS and ENDRA […]
   ENDRA Life Sciences to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Monday, August 17, 2020 at 4:30 p.m. ET | MarketScreener  2020/08/05 20:57:11 MarketScreener
ANN ARBOR, MI / ACCESSWIRE / August 5, 2020 /ENDRA Life Sciences Inc. , a pioneer of Thermo Acoustic Enhanced UltraSound , today announced that its second quarter financial results… | August 5, 2020

calendar